Key themes and keynotes

We invite abstracts on all aspects of drug policy but particularly on the conference themes. The conference themes this year include:

  • Regulatory options and policy alternatives for currently illicit drugs
  • The opioid crisis
  • Diversity in drug policy: accommodating ethnicity, class, gender and culture
  • Comparative policy analyses
  • Relations between drug policies on international, national and local levels
  • The role of different kinds of stakeholders and their position in drug policy
  • Drug supply and suppliers
  • Policies towards non-medical uses of prescription drugs
  • Methodological and theoretical developments in drug policy analysis
  • Internet markets for illicit drugs
  • The use of social network analysis to inform drug policy
  • Peer engagement/user involvement in drug policy
  • The crossover of harm reduction between illicit drugs and other substances

Keynotes

Dr. Rosario Queirolo

Rosario Queirolo is Associate Professor and Chair of the Department of Social and Political Sciences at Universidad Católica del Uruguay. She obtained her Ph.D in Political Science at University of Pittsburgh.

Queirolo works in two main research areas: comparative politics and drugs policies. She is specialized on electoral behavior and public opinion studies in Latin America, and has published several articles and book chapters around these topics. Her book The Success of the Left in Latin America has just been published by University of Notre Dame Press.

Since 2013, Queirolo has been working in the drug policy field, in particular studying the process of marijuana regulation in Uruguay and the region. She is part of the Latin American Marijuana Research Initiative (LAMRI), which was established to monitor the process of cannabis regulation in Uruguay. She has published articles in the International Journal of Drug Policy, Drug and Alcohol Review, Journal of Drug Issues and Drugs: Education, Prevention & Policy among others.

Keynote presentation: Wednesday, May 16th, 9:30 - 10:15 AM, Oceanview 5/6

Dr. Mark Tyndall

Mark Tyndall is the Executive Director of the British Columbia Center for Disease Control, deputy Provincial Health Officer and a Professor at the UBC School of Population and Public Health.  He is an Infectious Disease specialist, epidemiologist and public health expert who has dedicated his career to studying HIV, poverty and drug use, starting in Nairobi, Kenya, and now in Vancouver, Canada. An early advocate for harm reduction programs, Mark was at the forefront of evaluating North America’s first legally sanctioned supervised injection facility, INSITE, established in Vancouver in 2003. Since then, studies have shown that safe injection sites save lives, reduce transmission of disease and help people access addiction treatment.  An advocate for evidence-based public health policy and interventions, Mark has been an author on over 250 academic papers, and has received several honors for his work.

Keynote presentation: Thursday, May 17th, 9:00 - 9:45 AM, Oceanview 5/6

Dr. Mark A. Ware

Dr. Ware is Associate Professor in Family Medicine and Anesthesia at McGill University. He is Director of Clinical Research of the Alan Edwards Pain Management Unit at the McGill University Health Centre. A family physician, Dr Ware’s research interests include evaluating the safety and efficacy of cannabis and cannabinoids in pain and symptom management. In 2016 he served as the vice chair of the federal Task Force on the legalization and regulation of cannabis in Canada.

Keynote presentation: Thursday, May 17th, 3:00 - 3:45 PM, Oceanview 5/6

Mr. John-Peter Kools

John-Peter Kools is an international expert on drug use, health and harm reduction. Mr Kools is working as senior drug policy advisor at the Trimbos Institute in The Netherlands. He has been involved in the drug field since the mid 80s. He was involved in the development of the first ever needle and syringe programme and other harm reduction initiatives, later on also as an initiator of public health programmes for People Who Use Drugs in his home country. Since the mid 90s he has been involved in supporting public health and harm reduction programmes in Eastern Europe, Asia and Africa. From 2010 to 2017 Kools was the chair of Harm Reduction International.

Keynote presentation; Franz Trautmann Memorial Lecture: Friday, May 18th, 12:00 - 12:45 PM, Oceanview 5/6